Public health
Are outcomes, access, quality controls, prevention, treatment, and harm reduction measured?
FROM STATIC OBSERVATORY TO REVIEWABLE EVIDENCE
A policy announcement is not a market outcome.
Document what changed, which primary source establishes it, who gains or loses power, and whether the evidence points toward public protection—or a new failure mode.
Create an evidence record →Transition record
What changed—and what evidence exists?
Use public, non-confidential information. Record one policy, rule, market event, court decision, licensing development, acquisition, patent event, or implementation result at a time.
0% evidence record completeBrowser-local autosave ready
Six-dimension review
“Toward” and “away” are analytical judgments. Every judgment should have an evidence note; “unknown” is a valid result.
Human rights
Are criminalization, discrimination, due process, liberty, and proportionality impacts documented?
Equity & participation
Are affected communities shaping the transition and receiving durable access, ownership, or repair?
Market power
Do licensing, finance, IP, advertising, and vertical integration rules limit concentration and capture?
Indigenous rights
Are knowledge, land, consent, governance, and benefit sharing addressed on their own terms?
Development & environment
Are livelihoods, gender, conflict, public revenue, ecological effects, and cross-border impacts visible?
Current disposition
Evidence incomplete
0 toward · 0 mixed · 0 away · 6 unknown. This is a transparent synthesis of the judgments above, not a prediction or causal finding.
Completion requires four core provenance fields and an evidence note of at least 20 characters for each dimension. It measures record completeness, not policy quality.
Evidence routes
Start with the source that can establish the claim.
UNODC World Drug Report 2026
Downloadable global drug-market findings and datasets; useful for demand, supply, cultivation, trafficking, treatment, and harm context.
Open source →UNDP Development Dimensions
A rights- and development-oriented framework covering health, governance, inequity, corporate capture, gender, Indigenous rights, and environmental impacts.
Open source →Transform practical guides
Regulatory design resources for cannabis, psychedelics, stimulants, and post-prohibition market governance.
Open source →Research archive · snapshot July 27, 2026
Seven analytical lenses preserved.
These pages are a dated interpretive research library. They do not refresh automatically and should be re-checked against current primary sources before use.
ARCHIVE 01
Corporate Capture Watch
Is this transition finding the sweet spot, or replicating the Altria-Cronos dynamic?
ARCHIVE 02Patents & IP
Is intellectual property advancing public health or building access barriers?
ARCHIVE 03Indigenous Knowledge & Benefit Sharing
Are commercialisation processes respecting Indigenous knowledge?
ARCHIVE 04State Equity Programs
Are social equity provisions substantively effective or performatively inclusive?
ARCHIVE 05Development Lens
Are drug market transitions supporting sustainable development goals?
ARCHIVE 06Psychedelic Commercialisation Index
Which regulatory tier does each development enable, restrict, or foreclose?
ARCHIVE 07Transform Research Notes
What is Transform's active research output and implementation record?
Scoped support
Need the sources retrieved and the record completed?
RN Collins can research a jurisdiction, trace claims to primary authorities, construct the evidence register, identify gaps, and design a monitoring or decision workflow around the question.
Discuss the question on LinkedIn →